Picture of Interpace Biosciences logo

IDXG Interpace Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Interpace Diagnostics Sees FY18 Revenue More Than $20 Mln

Oct 10 (Reuters) - Interpace Diagnostics Group Inc  IDXG.O :
    * INTERPACE DIAGNOSTICS CEO PROVIDES CORPORATE UPDATE
    * SEES FY 2018 REVENUE MORE THAN $20 MILLION

Source text for Eikon:  ID:nGNX1QSn4w 
Further company coverage:  IDXG.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Interpace Biosciences

See all news